Review Neutrophil Gelatinase-Associated Lipocalin (NGAL): Perannya sebagai Biomarker pada Kerusakan Ginjal Akut
Article Sidebar
Main Article Content
Abstract
Kerusakan ginjal akut merupakan penyakit yang berisiko tinggi menyebabkan pasien kritis hingga kematian, membutuhkan diagnosis yang cepat dalam penanganannya. Saat ini pendeteksian penyakit kerusakan ginjal akut masih terbatas dan belum dilakukan secara umum untuk dijadikan standar biomarker yang cepat dan tepat. Neutrophil gelatinase-associated lipocalin (NGAL) merupakan protein lipocalin 25 kDa yang terdapat pada sel epitel ginjal dan hati. NGAL dapat merespon langsung terjadinya kerusakan pada sel tubular epitel, ditandai dengan meningkatnya NGAL dalam urin dan plasma, sehingga NGAL dapat dijadikan penanda kerusakan ginjal akut dengan cepat dengan sensitivitas dan spesifisitas tinggi. Metode yang digunakan dalam review artikel ini menggunakan penelusuran melalui PubMed. Tujuan review artikel ini adalah untuk menunjukkan bahwa NGAL dapat dijadikan penanda gagal ginjal akut yang cepat dan sensitif.
Kata Kunci: Kerusakan ginjal akut; biomarker NGAL; pengujian NGAL; sensitivitas; selektfitas.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
Singer E, Markó L, Paragas N, Barasch J, Dragun D, Müller DN, et al. Neutrophil gelatinase-associated lipocalin: Pathophysiology and clinical applications. Acta Physiol 2013;207:663–72. https://doi.org/10.1111/apha.12054.
Levey AS, James MT. Annals graphic medicine - The problem list. Ann Intern Med 2017;167:ITC65–79. https://doi.org/10.7326/AITC201711070.
Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015;41:1411–23. https://doi.org/10.1007/s00134-015-3934-7.
Lagos-arevalobsc P, Palijan A, Vertullobsc L, Devarajan P, Gottesman RD, Zappitelli M. HHS Public Access 2016;30:665–76. https://doi.org/10.1007/s00467-014-2987-0.Cystatin.
Seibert FS, Sitz M, Passfall J, Haesner M, Laschinski P, Buhl M, et al. Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease. Kidney Blood Press Res 2018;43:1255–62. https://doi.org/10.1159/000492407.
De Geus HR, Fortrie G, Betjes MG, Van Schaik RH, Groeneveld AJ. Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patients. BMC Nephrol 2013;14. https://doi.org/10.1186/1471-2369-14-273.
Albeladi FI, Algethamy HM. Urinary Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Acute Kidney Injury, Severe Kidney Injury, and the Need for Renal Replacement Therapy in the Intensive Care Unit. Nephron Extra 2017;7:62–77. https://doi.org/10.1159/000477469.
Mårtensson J, Bellomo RR. The rise and fall of NGAL in acute kidney injury. Blood Purif 2014;37:304–10. https://doi.org/10.1159/000364937.
Clerico A, Galli C, Fortunato A, Ronco C. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: A review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012;50:1505–17. https://doi.org/10.1515/cclm-2011-0814.
Devarajan P. NGAL for the detection of acute kidney injury in the emergency room. Biomark Med 2014;8:217–9. https://doi.org/10.2217/bmm.13.149.
Zhang J, Han J, Liu J, Liang B, Wang X, Wang C. Clinical significance of novel biomarker NGAL in early diagnosis of acute renal injury. Exp Ther Med 2017;14:5017–21. https://doi.org/10.3892/etm.2017.5150.
Ghonemy TA, Amro GM. Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery. Saudi J Kidney Dis Transpl 2014;25:582–8. https://doi.org/10.4103/1319-2442.132194.
Afify MFM, Maher SE, Ibrahim NM, El-Hamied WMA. Serum Neutrophil Gelatinase-Associated Lipocalin in Infants and Children with Sepsis-Related Conditions with or without Acute Renal Dysfunction. Clin Med Insights Pediatr 2016;10:CMPed.S39452. https://doi.org/10.4137/cmped.s39452.
Park SY, Eom JS, Lee JS, Ju YS, Park JY. Neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in patients during treatment with colistimethate sodium. Infect Chemother 2018;50:128–37. https://doi.org/10.3947/ic.2018.50.2.128.
Cruz DN, De Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010;36:444–51. https://doi.org/10.1007/s00134-009-1711-1.
Ataei N, Ameli S, Yousefifard M, Oraei A, Ataei F, Bazargani B, et al. Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C in Early Detection of Pediatric Acute Kidney Injury; a Diagnostic Accuracy Study. Emergency 2018;6:e2–e2. https://doi.org/10.22037/emergency.v6i1.17782.
Mohtashami AZ, Hadian B, Mahmoudi GA, Anbari K, Salahbarzin A. The Application of Urinary NGAL Measurement for Early Detection of AKI in Hospitalized Patients with Poisoning 2020;14:206–11.
Heart IJC, Banai A, Rozenfeld K, Lewit D, Merdler I, Loewenstein I, et al. Neutrophil gelatinase-associated lipocalin ( NGAL ) for the prediction of acute kidney injury in chronic kidney disease patients treated with primary percutaneous coronary intervention q. IJC Hear Vasc 2021;32:100695. https://doi.org/10.1016/j.ijcha.2020.100695.
Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: A multicenter prospective cohort study. J Am Coll Cardiol 2012;59:246–55. https://doi.org/10.1016/j.jacc.2011.10.854.
Krzeminska E, Wyczalkowska-Tomasik A, Korytowska N, Paczek L. Comparison of Two Methods for Determination of NGAL Levels in Urine: ELISA and CMIA. J Clin Lab Anal 2016;30:956–60. https://doi.org/10.1002/jcla.21962.